Capital Flow Monitor · Sponsors · CIK 1613386
Aminex Therapeutics, Inc.
6830 NE Bothell Way Ste C139, Kenmore, WA, 98028 · 425-286-4222
Biotechnology · Corporation· inc. WASHINGTON true
Fit score
—
Offering
$30.0M
Sold
$15.1M
% sold
50.3%
Investors
162
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-12-05 | D ·current | 506(b) | $30.0M | $15.1M | 50.3% | 162 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- David Meeks — Director, Kenmore, WA
- Mark Burns — Executive Officer / Director, Kenmore, WA
- Don Dyer — Director, Kenmore, WA
-
Jeffrey Miller — Director, Kenmore, WA
4 other raises
- LMnT Ventures II, L.P. $0 of $80.0M · 0.0%
- Clarity Technology Solutions Inc. $4.4M of $4.4M · 100.0%
- Pantheon Global Co-Investment Opportunities Fund VI Feeder (US) LP $50.0M of —
- LMNT Ventures, L.P. $36.2M of $36.2M · 100.0%
- Deyaa Adib — Director, Kenmore, WA
- James Skaggs — Director, Kenmore, WA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.